Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$67.65
+1.3%
$64.86
$43.56
$72.51
$84.52B0.5610.87 million shs10.27 million shs
Danaher Corporation stock logo
DHR
Danaher
$197.51
+0.6%
$194.11
$171.00
$281.70
$140.51B0.773.46 million shs2.74 million shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$376.48
+1.1%
$396.08
$357.45
$567.26
$84.14B0.61.57 million shs1.06 million shs
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$11.35
$11.18
$8.08
$16.00
$9.82B0.7820.60 million shs7.95 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
+1.08%+0.77%+11.27%+0.73%+9.58%
Danaher Corporation stock logo
DHR
Danaher
+0.52%+0.87%+6.88%-6.01%-23.08%
Elevance Health, Inc. stock logo
ELV
Elevance Health
+1.06%+0.36%+1.11%-12.51%-30.53%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
0.00%-0.35%+1.61%+2.25%-28.66%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CVS Health Corporation stock logo
CVS
CVS Health
4.9909 of 5 stars
3.54.03.33.92.93.33.1
Danaher Corporation stock logo
DHR
Danaher
4.9612 of 5 stars
4.44.01.74.23.13.31.3
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.9734 of 5 stars
4.45.04.20.03.22.53.1
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
2.8999 of 5 stars
0.94.00.02.32.73.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.95
Moderate Buy$75.0710.96% Upside
Danaher Corporation stock logo
DHR
Danaher
2.80
Moderate Buy$248.6125.87% Upside
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.75
Moderate Buy$498.8732.51% Upside
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
1.83
Reduce$10.59-6.69% Downside

Current Analyst Ratings Breakdown

Latest CVS, WBA, DHR, and ELV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Danaher Corporation stock logo
DHR
Danaher
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$215.00 ➝ $225.00
6/9/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$510.00 ➝ $500.00
6/5/2025
Danaher Corporation stock logo
DHR
Danaher
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$240.00 ➝ $235.00
6/4/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$478.00
6/2/2025
CVS Health Corporation stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$82.00 ➝ $79.00
6/2/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$522.00 ➝ $480.00
5/12/2025
CVS Health Corporation stock logo
CVS
CVS Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$82.00 ➝ $84.00
5/6/2025
CVS Health Corporation stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$76.00 ➝ $84.00
5/5/2025
CVS Health Corporation stock logo
CVS
CVS Health
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/5/2025
CVS Health Corporation stock logo
CVS
CVS Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$74.00 ➝ $81.00
5/2/2025
CVS Health Corporation stock logo
CVS
CVS Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$67.00 ➝ $71.00
(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$378.96B0.23$9.20 per share7.35$60.18 per share1.12
Danaher Corporation stock logo
DHR
Danaher
$23.88B5.92$10.99 per share17.97$68.60 per share2.88
Elevance Health, Inc. stock logo
ELV
Elevance Health
$177.01B0.48$39.59 per share9.51$178.62 per share2.11
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$147.66B0.07$5.73 per share1.98$13.91 per share0.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$4.61B$4.1916.159.990.961.39%10.59%3.17%8/6/2025 (Estimated)
Danaher Corporation stock logo
DHR
Danaher
$3.90B$5.1538.3523.052.7615.81%10.80%6.89%7/22/2025 (Estimated)
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.98B$25.6314.699.640.953.23%18.61%6.80%7/16/2025 (Estimated)
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-$8.64B-$6.69N/A7.771.37-3.80%16.39%2.39%6/26/2025 (Estimated)

Latest CVS, WBA, DHR, and ELV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Danaher Corporation stock logo
DHR
Danaher
$1.64N/AN/AN/A$5.83 billionN/A
7/16/2025Q2 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$9.30N/AN/AN/A$48.26 billionN/A
6/26/2025Q3 2025
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$0.34N/AN/AN/A$36.72 billionN/A
5/1/2025Q1 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.62$2.25+$0.63$1.41$93.07 billion$94.59 billion
4/22/2025Q1 2025
Danaher Corporation stock logo
DHR
Danaher
$1.62$1.88+$0.26$1.32$5.58 billion$5.74 billion
4/22/2025Q1 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.60$11.97+$1.37$9.61$46.26 billion$48.77 billion
4/8/2025Q2 2025
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$0.53$0.63+$0.10-$3.30$37.90 billion$38.59 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.93%N/A63.48%4 Years
Danaher Corporation stock logo
DHR
Danaher
$1.280.65%N/A24.85%2 Years
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.841.82%N/A26.69%14 Years
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
N/AN/AN/AN/AN/A

Latest CVS, WBA, DHR, and ELV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2025
Danaher Corporation stock logo
DHR
Danaher
quarterly$0.320.67%6/27/20257/25/2025
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.711.6%6/10/20256/10/20256/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.77
0.82
0.63
Danaher Corporation stock logo
DHR
Danaher
0.31
1.43
1.05
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.66
1.43
1.43
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
0.92
0.61
0.32

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Danaher Corporation stock logo
DHR
Danaher
79.05%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
58.59%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
1.22%
Danaher Corporation stock logo
DHR
Danaher
11.20%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
17.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.27 billion1.25 billionOptionable
Danaher Corporation stock logo
DHR
Danaher
63,000715.67 million635.52 millionOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
104,200225.93 million225.28 millionOptionable
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
312,000865.56 million714.09 millionOptionable

Recent News About These Companies

Is Walgreens Stock Underperforming the Nasdaq?

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVS Health stock logo

CVS Health NYSE:CVS

$67.65 +0.84 (+1.26%)
Closing price 06/24/2025 03:59 PM Eastern
Extended Trading
$67.28 -0.38 (-0.56%)
As of 06:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Danaher stock logo

Danaher NYSE:DHR

$197.51 +1.17 (+0.60%)
Closing price 06/24/2025 03:59 PM Eastern
Extended Trading
$197.84 +0.33 (+0.16%)
As of 06:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Elevance Health stock logo

Elevance Health NYSE:ELV

$376.48 +4.06 (+1.09%)
Closing price 06/24/2025 03:59 PM Eastern
Extended Trading
$376.42 -0.06 (-0.01%)
As of 05:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Walgreens Boots Alliance stock logo

Walgreens Boots Alliance NASDAQ:WBA

$11.35 0.00 (0.00%)
Closing price 06/24/2025 04:00 PM Eastern
Extended Trading
$11.35 0.00 (-0.04%)
As of 06:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.